- Published on Tuesday, 18 June 2013 05:42
- Written by André Lowe, Jamaica Gleaner
- Hits: 1780
The Gleaner understands that Jamaican sprinting star Veronica Campbell-Brown had in fact declared using a product ahead of her positive drug test - a development, which could have a major impact on the outcome of the situation facing the 31-year-old.
Importantly, however, it is also understood that there was no Therapeutic Use Exemption (TUE) in place, which means that she will still need to face a hearing.
The TUE is a pre-approved facility, which allows athletes to use certain banned substances for medical conditions.
Campbell-Brown's 'A' sample, taken after her performance at the May 4 Jamaica International Invitational at the National Stadium, returned an adverse analytical finding, reportedly triggered by the presence of a diuretic.
Up to last night, the Jamaica Athletics Administrative Association (JAAA) had not received official notification of the findings of Campbell-Brown's 'B' sample, but the association's president, Dr Warren Blake, on Saturday did confirm that a Jamaican athlete had returned an adverse analytical finding from their 'A' sample at the meet.
Diuretics are banned by the World Anti-Doping Agency (WADA) for their ability to mask the presence of performance-enhancing drugs.
However, sources close to the situation informed that the athlete had notified the doping control authorities that she had taken medication, with the subsequent tests turning up the presence of banned substances.